Formidable Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,597
Closed -$234K 407
2026
Q1
$234K Sell
4,597
-3,097
-40% -$147K 0.04% 350
2025
Q4
$427K Sell
7,694
-15,268
-66% -$781K 0.06% 268
2025
Q3
$1.58M Buy
22,962
+7,014
+44% +$411K 0.25% 78
2025
Q2
$1.11M Hold
15,948
0.19% 107
2025
Q1
$1.11M Buy
15,948
+1,372
+9% +$113K 0.19% 106
2024
Q4
$1.25M Buy
14,576
+7,857
+117% +$850K 0.21% 93
2024
Q3
$800K Buy
+6,719
New +$896K 0.13% 155

Other funds holding NVO

Formidable Asset Management's NVO Position: Q2 2026 in Review

Formidable Asset Management sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 4,597 shares — an estimated $234K sold.

Formidable Asset Management first reported a position in NVO in Q3 2024 and held it in 7 quarters. The position peaked at $1.58M in Q3 2025. 240 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Formidable Asset Management reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • Formidable Asset Management sold 4,597 Novo Nordisk shares in Q2 2026, an estimated $234K.
  • Formidable Asset Management first reported a position in Novo Nordisk in Q3 2024 and held it in 7 quarters.
  • Formidable Asset Management's Novo Nordisk position peaked at $1.58M in Q3 2025.
  • 240 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Formidable Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.